Agios Pharmaceuticals | AGIO - 股票



金融业
股票价格
USD
资产
USD 1.3B
现金及等价物
USD 89.13M
销售成本
USD 1.88M
流动资产
USD 942.05M
流动负债
USD 82.21M
债务
USD 44.52M
EBIT
USD -121.58M
EBITDA
USD -115.5M
员工
486
EPS每股收益
USD -1.86
股本和储备
USD 1.19B
销售毛利
USD 18.09M
债务利息支出
USD 1.39B
利息收入
USD 13.37M
贷款资金
USD 1.06M
市值
USD 1.62B
净收入
USD -108.04M
营业费用
USD 141.55M
营业利润
USD -121.58M
普通股股本
USD 58.45M
PE价格收益
3.56
税前利润
USD -109.06M
销售收入
USD 19.97M
销售和管理费用
USD 42.97M
股票
USD 32.92M
贸易债权人
USD 18.36M
应收帐款人
USD 10.58M


股票 更改 日
AbbVie USD 4.95B 13M 2025-12
Agios Pharmaceuticals USD 32.92M 886K 2025-12
Alnylam Pharmaceuticals USD 82.72M 7.34M 2025-12
Amgen USD 6.22B 121M 2025-12
Arrowhead Research USD -173.08M 173.08M 2024-12
Astellas Pharma JPY 297.26B 9.92B 2025-03
AstraZeneca USD 6.59B 126M 2025-09
Bayer EUR 12.33B 221M 2025-09
Biogen USD 2.17B 41.3M 2025-12
BioMarin Pharmaceutical USD 1.3B 83.29M 2025-12
Bristol-Myers Squibb USD 2.76B 21M 2025-09
Daiichi Sankyo JPY 608.55B 93.64B 2025-09
Eli Lilly USD 13.74B 1.56B 2025-12
Exelixis USD 27.4M 3.92M 2025-09
Gilead Sciences USD 1.78B 40M 2025-09
GlaxoSmithKline GBP 6.12B 46M 2025-09
Incyte USD 101.06M 17.61M 2025-12
Ionis Pharmaceuticals USD 10.47M 1.99M 2025-09
Merck USD 6.44B 157M 2025-09
Moderna USD 332M 92M 2025-09
Nektar Therapeutics USD 14.46M 1.78M 2024-06
Novartis USD 6.42B 114M 2025-09
Novartis USD 6.42B 114M 2025-09
Pfizer USD 11.47B 201M 2025-09
Puma Biotechnology USD 9.48M 885K 2025-09
Regeneron Pharmaceuticals USD 3.2B 53.6M 2025-12
Roche Holding CHF 7.6B 9M 2025-06
Sarepta Therapeutics USD 914.74M 162.42M 2025-12
Vertex Pharmaceuticals USD 1.69B 60M 2025-12